Publication | Open Access

IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain

Neuro-oncologyAtezolizumab Plus BevacizumabMedicinePathologyCancer TreatmentCancer GeneticsEgfr MutationsOncologyRadiation OncologyLung CancerMolecular Oncology